Search

23 Feb 2024: Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease.

23 Feb 2024: DOI: 10.1038/s41598-017-12740-6. Martin J, Ponstingl H … Bradley A;Comprehensive annotation and evolutionary insights into the canine (Canis lupus familiaris) antigen receptor loci.

23 Feb 2024: We have a particular interest in how tissue immune cells work with epithelial cells to defend the kidney from infection but play pathogenic roles in autoimmune diseases like lupus nephritis or ... Distinct pathogenic roles for resident and

23 Feb 2024: CITIID is already driving therapeutic breakthroughs in immune-mediated disease such as inflammatory bowel disease and systemic lupus erythematosus.

23 Feb 2024: They include tests for lupus, multiple sclerosis, diabetes mellitus and rheumatoid arthritis.

23 Feb 2024: David Jayne. Evaluates immunotherapeutics in vasculitis, lupus and immune-mediated renal disease and co-ordinates the European Vasculitis Study Group (EUVAS) and multi-centre randomised controlled trials.

uploads/2019/03/DavidJayne-HQ-819x1024.jpg 819w" sizes="(max-width: 240px) 100vw, 240px" //a/pnpClinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease.

DOI: 10.1038/s41598-017-12740-6/pnpbMartin J/b, Ponstingl H u2026 Bradley A;Comprehensive annotation and evolutionary insights into the canine (Canis lupus familiaris) antigen receptor loci.

They include tests for lupus, multiple sclerosis, diabetes mellitus and rheumatoid arthritis./pnpbProfessor Arthur Kaser/b/pn","protected":false},"excerpt":{"rendered":"pOne in every three-hundred people has inflammatory bowel disease

to Lead Developments in Immune-Mediated Disease/h1npCITIID is already driving therapeutic breakthroughs in immune-mediated disease such as inflammatory bowel disease and systemic lupus erythematosus.